SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-015469
Filing Date
2018-08-14
Accepted
2018-08-14 10:04:03
Documents
42
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q relv20180630_10q.htm 10-Q 915290
2 EXHIBIT 31.1 ex_121438.htm EX-31.1 14937
3 EXHIBIT 31.2 ex_121439.htm EX-31.2 14363
4 EXHIBIT 32 ex_121440.htm EX-32 6664
  Complete submission text file 0001437749-18-015469.txt   3396859

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT relv-20180630.xml EX-101.INS 639733
6 XBRL TAXONOMY EXTENSION SCHEMA relv-20180630.xsd EX-101.SCH 28010
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE relv-20180630_cal.xml EX-101.CAL 38318
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE relv-20180630_def.xml EX-101.DEF 191548
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE relv-20180630_lab.xml EX-101.LAB 184953
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE relv-20180630_pre.xml EX-101.PRE 206420
Mailing Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405
Business Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405 636-537-9715
RELIV INTERNATIONAL INC (Filer) CIK: 0000768710 (see all company filings)

IRS No.: 371172197 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19932 | Film No.: 181014906
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1